Research

As executive director for women’s health, a role that complements her position leading obstetrics and gynecology, Dr. Riley will unify, coordinate and drive new paradigms for women’s health care across medical specialties.

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. 

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. 

The lecturership recognizes Dr. Lyden's transformative contributions to cancer research.

We sat down with Dr. Jia Ruan to learn more about her clinical research and how she thinks it will help lymphoma patients.

Dr. Won Jun Kim, Tri-Institutional M.D.-Ph.D. student, was named a winner of the 2026 Harold M. Weintraub Graduate Student Award by the Fred Hutchinson Cancer Center. 

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop...

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

Awards, honors and achievements for the month of March.

Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation. 

NEW YORK (March 25, 2026)—Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced...

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. 

An enigmatic type of circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine. 

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. 

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. 

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. 

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.

Fourteen members of Cornell’s faculty and staff are being recognized this year with Community-Engaged Practice and Innovation Awards from the David M. Einhorn Center for Community Engagement. 

A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.